Importance of Subgroups in Heart Failure Clinical Trials - Part 2

7 snips

Jan 10, 2024

Guest

Mitchell Psotka

Experts in heart failure clinical trials, including Scott Solomon and JoAnn Lindenfeld, discuss the importance of analyzing subgroups in trials. They emphasize the challenges in interpreting data, the impact of therapy, and the need for personalized medicine for better treatment outcomes.

Ask episode

Chapters

Transcript

Episode notes

Introduction

00:00 • 3min

Rigor in Analyzing Subgroups in Clinical Trials

02:54 • 14min

Analysis of Treatment Effects in Heart Failure Subgroups and Trial Outcomes

17:23 • 3min

Analysis of Heart Failure Clinical Trials and FDA Decision Making

20:19 • 6min

Importance of Subgroups in Heart Failure Clinical Trials and the Need for Personalized Medicine

26:11 • 3min